{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:06:58Z","timestamp":1760645218627},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.clinthera.2006.08.008","type":"journal-article","created":{"date-parts":[[2006,9,19]],"date-time":"2006-09-19T11:16:16Z","timestamp":1158664576000},"page":"1164-1174","source":"Crossref","is-referenced-by-count":14,"title":["A post hoc subgroup analysis of meropenem versus imipenem\/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus"],"prefix":"10.1016","volume":"28","author":[{"given":"John M.","family":"Embil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto E.","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2006.08.008_bib1","first-page":"637","article-title":"Complicated infections of skin and skin structures: When the infection is more than skin deep","volume":"53","author":"DiNubile","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2006.08.008_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2006.08.008_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0732-8893(02)00468-6","article-title":"Skin and soft tissue infections in Latin American medical centers: Four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns","volume":"44","author":"Sader","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2006.08.008_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2006.08.008_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1086\/424846","article-title":"Diagnosis and treatment of diabetic foot infections","volume":"39","author":"Lipsky","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2006.08.008_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1067-2516(00)80009-5","article-title":"Antibiotic selection for diabetic foot infections: A review","volume":"39","author":"Cunha","year":"2000","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/j.clinthera.2006.08.008_bib7","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2165\/00003495-200363140-00003","article-title":"A practical guide to the treatment of complicated skin and soft tissue infections","volume":"63","author":"Fung","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2006.08.008_bib8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2165\/00003495-200464150-00002","article-title":"Newer treatment options for skin and soft tissue infections","volume":"64","author":"Raghavan","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2006.08.008_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0732-8893(02)00543-6","article-title":"Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: Report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)","volume":"45","author":"Rennie","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2006.08.008_bib10","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archderm.134.8.1006","article-title":"Analysis of antibiotic susceptibilities of skin wound flora in hospitalized dermatology patients. The crisis of antibiotic resistance has come to the surface","volume":"134","author":"Colsky","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clinthera.2006.08.008_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1464-5491.1992.tb01796.x","article-title":"The distribution and severity of diabetic foot disease: A com munity study with comparison to a non-diabetic group","volume":"9","author":"Walters","year":"1992","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2006.08.008_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2337\/diacare.21.4.506","article-title":"The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications","volume":"21","author":"Yosipovitch","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2006.08.008_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0924-8579(03)00154-7","article-title":"Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: A guide to appropriate antimicrobial therapy","volume":"22","author":"Jones","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2006.08.008_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/clinids\/23.2.286","article-title":"Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation?","volume":"23","author":"Tan","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2006.08.008_bib15","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/AAC.43.8.2056","article-title":"Penetration of ciprofloxacin into the interstitial space of in flamed foot lesions in non-insulindependent diabetes mellitus patients","volume":"43","author":"Muller","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2006.08.008_bib16","first-page":"295","article-title":"Treatment of polymicrobial intra-abdominal, pelvic, and diabetic foot infections","volume":"24","author":"Zervos","year":"1998","journal-title":"Compr Ther."},{"key":"10.1016\/j.clinthera.2006.08.008_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V","article-title":"Impaired leucocyte functions in diabetic patients","volume":"14","author":"Delamaire","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2006.08.008_bib18","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","article-title":"Infections in patients with diabetes mellitus.","volume":"341","author":"Joshi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2006.08.008_bib19","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1464-5491.1994.tb00250.x","article-title":"Infections and diabetes: Mechanisms and prospects for prevention","volume":"11","author":"Pozzilli","year":"1994","journal-title":"Diabet Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2006.08.008_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jac\/dkg466","article-title":"Expert panel on managing skin and soft tissue infections. Managing skin and soft tissue infections: Expert panel recommendations on key decision points","volume":"52","author":"Eron","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2006.08.008_bib21","series-title":"Merrem IV (meropenem for injection)","year":"2005"},{"key":"10.1016\/j.clinthera.2006.08.008_bib22","series-title":"Primaxin IV (imipenem and cilastatin for injection)","year":"2005"},{"key":"10.1016\/j.clinthera.2006.08.008_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/sur.2005.6.269","article-title":"Meropenem versus imipenemcilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: Results of a multicenter, randomized, double-blind comparative study","volume":"6","author":"Fabian","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.clinthera.2006.08.008_bib24","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1016\/j.clinthera.2006.08.008_bib25","series-title":"Performance Standards for Antimicrobial Disk Suscep tibility Tests. Approved Standard","author":"National Committee for Clinical Laboratory Standards","year":"2000"},{"key":"10.1016\/j.clinthera.2006.08.008_bib26","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. Approved Standard","author":"National Committee for Clinical Laboratory Standards","year":"2001"},{"key":"10.1016\/j.clinthera.2006.08.008_bib27","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1086\/340348","article-title":"Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: Results of a prospective, randomized, double-blind multicenter study","volume":"34","author":"Graham","year":"2002","journal-title":"Clin Infect Dis."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806001883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T03:08:42Z","timestamp":1555816122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806001883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0149291806001883"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.08.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}